IP Library Granted Patent US 8,706,198
Granted Patent B2
US 8,706,198 · App. 13/173,414 · Granted Apr 22, 2014

Opacity technology

Inventor: Eric K. Mangiardi (Charlotte, NC)
Assignee: Quali-Med GmbH
A61M25/0108A61M25/10A61M5/007A61B6/481A61B2019/5454A61B2019/5466A61M2025/1079A61K49/00A61K49/04A61K49/06A61K49/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,706,198
App. No.
13/173,414
Granted
Apr 22, 2014
Kind
B2
Abstract

A catheter device comprising a chamber containing an opacity enhancing substance is disclosed. The opacity enhancing substance is in a dried or semi-dried form within the chamber of the device. Release of a liquid into the chamber suspends the substance and forms an opacity enhancing solution that is released into the lumen of the device in order to enhance the opacity of the device for imaging.

Claims (11)

1. A mixing device comprising a mixing chamber having a first port for connecting to a liquid delivery device, a second port for connecting to a catheter, and an opacity enhancing material inside the chamber,

wherein the opacity enhancing substance is disposed in a structure configured for placement inside the mixing chamber via a third port on the mixing chamber so that the opacity enhancing substance can become suspended, dissolved or diluted with a liquid received from the first port to form an opacity enhancing liquid.

2. The mixing device of claim 1 , wherein the catheter further comprises a balloon at the distal end, wherein the balloon is in fluid communication with the mixing chamber through a conduit.

3. The mixing device of claim 1 , wherein the opacity enhancing substance is selected from the group consisting of iodine compounds, barium sulfate, barium iridium, iron particles, tungsten, fluorescent dyes, gadolinium, and microbubbles.

4. The mixing device of claim 1 , wherein the catheter is selected from the group consisting of balloon catheters, vascular catheters, cardiac catheters, arterial catheters, venous catheters, neurovascular catheters, intestinal catheters, esophageal catheters, urinary catheters, and Foley catheters.

5. The mixing device of claim 1 , wherein the opacity enhancing substance is in a dried, semi-dried or liquid form.

6. The mixing device of claim 1 , wherein the mixing chamber further comprises a membrane or screen that separate the mixing chamber into two or more sections.

7. The mixing device of claim 1 , wherein the structure configured for placement inside the mixing chamber is a removable and replaceable cartridge.

8. The mixing device of claim 1 , wherein the opacity enhancing material is contained in a packet.

9. The mixing device of claim 1 , wherein the opacity enhancing material is contained in a tablet.

10. The mixing device of claim 1 , wherein the mixing chamber is configured to create a turbulent flow to mix the opacity enhancing substance with the liquid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2014
From: QUALI-MED GMBH
To: QUALIMED INNOVATIVE MEDIZINPRODUKTE GMBH
Reel/Frame 033376/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2011
From: MANGIARDI, ERIC K.
To: QUALI-MED GMBH
Reel/Frame 026730/0382 →
Continuity (3)
Provisional Application 61344355 · Jul 6, 2010
Provisional Application 61344543 · Aug 17, 2010
Related Publication 20120010503A1 · Jan 12, 2012